Crossmark

SGLT2 inhibitors and diabetic retinopathy: Insights from the management of nephropathy

Crossref DOI link: https://doi.org/10.1038/s41433-024-03472-9

Published Online: 2024-11-12

Published Print: 2025-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Varughese, Maria S. https://orcid.org/0009-0002-3022-5609
Varadhan, Lakshminarayanan https://orcid.org/0000-0003-1976-8071
License Information

Text and Data Mining valid from 2024-11-12

Version of Record valid from 2024-11-12
More Information

Article History

Received: 16 October 2024

Revised: 25 October 2024

Accepted: 6 November 2024

First Online: 12 November 2024

Competing interests

: The authors declare no competing interests.